Advertisement Bausch & Lomb and 20/10 Perfect Vision to form JV - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bausch & Lomb and 20/10 Perfect Vision to form JV

Bausch & Lomb, an eye health company, and 20/10 Perfect Vision, a provider of refractive surgery products, have announced their intent to form a joint venture focused on the laser vision correction industry.

The joint venture (JV) will combine the refractive eye surgery assets of both businesses, delivering 20/10 Perfect Vision’s promising new technology for the correction of presbyopia in conjunction with Bausch & Lomb’s development expertise and worldwide commercial reach. The transaction is expected to close by the end of 2008.

Gerald Ostrov, chairman and CEO of Bausch & Lomb, said: “We believe that our investment of assets in the joint venture will help advance the refractive industry, benefiting ophthalmologists and patients worldwide.

“20/10 Perfect Vision’s development of presbyopia-correcting treatments using its Femtec femtosecond laser – when paired with our proven refractive products, R&D insights and global sales and marketing resources – holds tremendous potential to stimulate.”